SMi Group’s 22nd annual European Pharmaceutical Market Access, Pricing and Reimbursement conference returns to London from 10-11 October 2016. The conference is one of the most established in the world, focusing on the changes in pricing and reimbursement and market access.

Key topics include:

• Updates on AMNOG and its implication on pricing and reimbursement
• How biosimilars are affecting your pricing strategy
• Capture on emerging markets’ regulatory framework to adapt your market access and P&R models
• Orphan drugs using recent examples to highlight the impact on pricing
• Cancer drug funding and budget cuts in the UK
• Innovative solutions beyond the pill
• Japanese and Turkish regional updates

CHAIRS FOR 2016:

• Bertram Häussler, Chairman of the Board of Management, IGES

• G ordon Spencer, Regional Market Access Lead - EU & Canada, Shire International GmbH

KEYNOTE SPEAKERS INCLUDE:

• Simone Breitkopf, Head HEOR, Governmental and Public Affairs, Alcon

• Ulf Staginnus, Head Market Access Oncology, Region Europe, Baxalta

• Alexander Natz, Secretary General, EUCOPE

• David Watson, Director of Pricing and PPRS, Association of the British Pharmaceutical Industry

• Panos Kefalas, Head of Health Economics and Market Access, Cell & Gene Therapy Catapult

and many more...